The abstract will be open to public viewing. Submit your abstract between July 1 and July 31, 2025 by 11:59 PM to reserve your spot at the symposium; again, only one form and one presenter per ...

This abstract is a sub-study of the TIGeR-PaC clinical trial. The combination product candidate (IAG), which is enabled by the FDA-cleared RenovoCath device, is currently under investigation and ...